Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. - Schweihofer, Verena; Bruss, Christina; Seitz, Stephan; Glehr, Gunther; Hetterich, Madeleine; Weber, Florian; Hatzipanagiotou, Maria; Álvarez, Miriam Fernández-Pacheco; Ortmann, Olaf; Brockhoff, Gero; Bauer, Richard J.; Wege, Anja Kathrin (Cancer Cell International, 2025)